Affimed N.V.
NASDAQ:AFMD
3.85 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 8.275 | 41.353 | 40.366 | 28.36 | 21.391 | 23.735 | 2.01 | 6.314 | 7.562 | 3.382 | 5.087 | 1.173 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 8.275 | 41.353 | 40.366 | 28.36 | 21.391 | 23.735 | 2.01 | 6.314 | 7.562 | 3.382 | 5.087 | 1.173 |
| Gross Profit Ratio
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 94.958 | 98.814 | 81.488 | 49.989 | 43.791 | 35.148 | 21.489 | 30.18 | 22.008 | 9.595 | 14.354 | 8.726 |
| General & Administrative Expenses
| 24.675 | 32.075 | 24.218 | 13.715 | 10.265 | 9.638 | 7.986 | 8.323 | 7.548 | 2.346 | 7.046 | 3.05 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 24.675 | 32.075 | 24.218 | 13.715 | 10.265 | 9.638 | 7.986 | 8.323 | 7.548 | 2.346 | 7.046 | 3.05 |
| Other Expenses
| 3.535 | 1.417 | 1.31 | 0.626 | -0.019 | 1.515 | 0.205 | 0.145 | 0.651 | 0.381 | 0.61 | 0.206 |
| Operating Expenses
| 119.413 | 130.889 | 105.706 | 63.704 | 54.037 | 44.786 | 29.475 | 38.503 | 29.556 | 11.941 | 21.4 | 11.776 |
| Operating Income
| -106.661 | -88.119 | -64.03 | -34.718 | -32.376 | -19.536 | -27.26 | -32.044 | -21.343 | -8.178 | -15.703 | -10.397 |
| Operating Income Ratio
| -12.89 | -2.131 | -1.586 | -1.224 | -1.514 | -0.823 | -13.562 | -5.075 | -2.822 | -2.418 | -3.087 | -8.864 |
| Total Other Income Expenses Net
| 4.965 | 2.117 | 6.509 | -6.647 | 0.015 | 2.166 | 0.205 | 0.145 | 0.651 | 0.381 | 0.61 | 0.204 |
| Income Before Tax
| -105.935 | -86.002 | -57.521 | -41.365 | -32.361 | -19.476 | -30.243 | -32.274 | -20.239 | -0.425 | -26.1 | -14.323 |
| Income Before Tax Ratio
| -12.802 | -2.08 | -1.425 | -1.459 | -1.513 | -0.821 | -15.046 | -5.111 | -2.676 | -0.126 | -5.131 | -12.211 |
| Income Tax Expense
| 0.003 | 0.002 | 0.002 | 0.001 | 0.004 | 0.001 | -0.02 | -0.058 | -21.343 | -0.166 | -0.001 | -0.009 |
| Net Income
| -105.938 | -86.004 | -57.523 | -41.366 | -32.365 | -19.477 | -30.223 | -32.216 | -20.239 | -0.259 | -26.099 | -14.314 |
| Net Income Ratio
| -12.802 | -2.08 | -1.425 | -1.459 | -1.513 | -0.821 | -15.036 | -5.102 | -2.676 | -0.077 | -5.131 | -12.203 |
| EPS
| -7.09 | -6.04 | -4.81 | -4.96 | -5.04 | -3.22 | -6.91 | -9.7 | -7.11 | -0.1 | -10.88 | -5.97 |
| EPS Diluted
| -7.09 | -6.04 | -4.81 | -4.96 | -5.04 | -3.22 | -6.91 | -9.7 | -7.1 | -0.1 | -10.88 | -5.97 |
| EBITDA
| -103.81 | -86.637 | -64.006 | -34.229 | -31.048 | -18.877 | -27.114 | -31.82 | -21.658 | -8.118 | -15.267 | -9.986 |
| EBITDA Ratio
| -12.545 | -2.095 | -1.586 | -1.207 | -1.451 | -0.795 | -13.49 | -5.04 | -2.864 | -2.4 | -3.001 | -8.513 |